DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
98 hedge funds and large institutions have $866M invested in Dicerna Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
Holders
98
Holding in Top 10
5
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$24.6M | |
| 2 | +$19.8M | |
| 3 | +$8.08M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$6.65M |
| 5 |
JP Morgan Chase
New York
|
+$6.33M |
Top Sellers
| 1 | -$37.2M | |
| 2 | -$13.4M | |
| 3 | -$3.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.39M |
| 5 |
Citigroup
New York
|
-$2.26M |